Evidence map›Paper›PMID 33303086›Full record

ArticleJournal of substance abuse treatment2021

Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency.

Kevin Wenzel, Marc Fishman

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03306368 nacompletednot on this map

Youth Opioid Recovery Support: A Developmentally-specific Intervention for Home Delivery of Extended Release Naltrexone

TypeinterventionalSponsorPotomac Health FoundationsRan2018 to 2019Enrolled40ConditionsOpioid-Related DisordersArmsYouth Opioid Recovery Support
NCT06774248 narecruitingnot on this mapstarted 2025, after this paper: background citation

Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD

TypeinterventionalSponsorPotomac Health FoundationsRan2025 to 2027Enrolled80ConditionsOpioid Use DisorderArmsYouth Opioid Recovery Support (YORS)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Mobile addiction treatment units: a narrative review.Addiction science & clinical practice · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kevin WenzelMountain Manor Treatment Center/Maryland Treatment Centers, 3800 Frederick Ave, Baltimore, MD 21229, USA. Electronic address: kwenzel@mountainmanor.org.
Marc FishmanMountain Manor Treatment Center/Maryland Treatment Centers, 3800 Frederick Ave, Baltimore, MD 21229, USA; Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, 600 N Wolfe St, Baltimore, MD 21205, USA.
Arthritis Treatment Center · US

Funding

The Youth Opioid Recovery Support (YORS) Intervention: An assertive community treatment model for improving medication adherence in young adults with opioid use disorderR33DA056230 · NIDA · MARYLAND TREATMENT CENTERS, INC. · PI FISHMAN, MARC, HAMMOND, CHRISTOPHER J. · 2021 to 2022
$3.0M
The Youth Opioid Recovery Support (YORS) Intervention: An assertive community treatment model for improving medication adherence in young adults with opioid use disorderR61AT010614 · NCCIH · MARYLAND TREATMENT CENTERS, INC. · PI FISHMAN, MARC · 2019 to 2019
$827k
NCCIH NIH HHS R61 AT010614NIDA NIH HHS R33 DA056230
6 · The paper itself

Abstract

The Youth Opioid Recovery Support (YORS) intervention is a novel treatment for young adults with opioid use disorder (OUD) that uses developmentally informed strategies to reduce barriers to treatment engagement. YORS strategies, such as home delivery of extended-release buprenorphine and extended-release naltrexone for OUD, are designed to increase engagement in treatment, but with the COVID-19 pandemic these strategies increase risk of virus exposure and spread to patients and staff entering homes. We present mobile van service delivery as a potential solution to continuing to provide low-barrier care for young adults with OUD while reducing risk associated with COVID-19. Initial feedback from patients and staff is positive and lays the groundwork to test feasibility and acceptability of this intervention rigorously in future work. Mobile van delivery of extended-release medications for OUD may be a promising treatment modification for mitigating risk of COVID-19, as well as a useful option for ongoing enhancement of care.

Indexed as

COVID-19Mobile Health UnitsBuprenorphineDelayed-Action PreparationsHumansNaltrexoneOpiate Substitution TreatmentOpioid-Related DisordersYoung AdultBuprenorphineDelayed-Action PreparationsNaltrexone

Identifiers

PMID33303086
PMCPMC13222066
OpenAlexW3088887115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.